Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
watch it go right back up.
shakeout time.
Digipath aspires to be like a LabCorp or Quest Diagnostics lab droppoff for cannabis testing....streamlining and expanding operations to many more cannabis testing sites in the future.
Digipath video update:
Digipath CEO mentioned they are still looking for a location for California lab. They ran into construction issues.
DIGP making bases and less people willing to sell at lower prices. Best to set it and forget it for a while...no need to rush it. Latest webcast from CEO says they have narrowed their search in Colombia to 3 sites. They are eager to open a lab in Bogota very soon. This year should be a good one for the company.
DIGP stock recently made a golden cross. 50 day is still hanging above the 200 day average. Could pop any time now.
Thanks for your insight. Keeping eyes open in all aspects of the cannabis sector. Gonna be huge in the U.S. when legalized at the Federal level all over.
Digipath currently has 1 lab in NV but is expanding with 3 more at HEMP INC. facilities soon and 1 lab in Colombia. I see that EVIO has many labs already. Will they open in Colombia? Digipath is claiming that half the future world cannabis production will come from Colombia. If they are right that would be a very lucrative market for any lab testing company. EVIO looks like agood lab testing company.....share price higher that Digipath but I hope DIGP can catch up soon.
Anybody have any opinion about Digipath compared to EVIO? Just curious. I am not familiar with EVIO.
Very low daily volume and interest in this company. You can see by the chart the gap up it has made since January. It is holding nicely above .20. It seems to be consolidating. Some decent news could have this flying fast.
In the last 6 trading sessions DIGP has bounced off the 50 day moving average multiple times only to finish at or near the high of the day. A few months back this was .09. I think higher prices are coming. The partnership with HEMP is solid. Digipath will have 3 new labs at HEMP facilities fully owned by Digipath when the buildout is done. Colombia expansion will be very lucrative...first-mover advantage for them in what will be a massive cannabis market down there. Export/imports all need to be tested. They made 2.8 mil from 1 lab this past year. Multiply that by 3 more labs and likely more when HEMP expands their production facilites to other states....likely they will expand Digipath partnership as well.
MM's trying to take down DIGP today. Chart is in a bullish wedge. 50 day crossed over the 200 day and holding above that this past week. Very Bullish! This is going to go to .50 at the very least if not $1 soon. Digipath is expanding labs and going to Colombia for International growth as well.
Digipath stock sverely undervalued here.....pounding the table here.
Emerging Markets Report: $2.5 Billion Reasons http://www.baystreet.ca/viewarticle.aspx?id=536316
Digipath stock chart signals a bullish move soon after consolidating. 50 day has crossed over the 200 day. I see a move to .50 soon. The news has been good lately and the stock is ready to move higher.
Digipath is #10 on this list of top cannabis testing labs. https://www.openpr.com/news/1590068/Cannabis-Testing-Market-to-Reflect-Impressive-Growth-Rate-by-2027-Top-Companies-Agilent-Technologies-PerkinElmer-Shimadzu-Corporation-SCIEX-Merck-KGaA-Restek-Corporation-Waters-CannaSafe-Analytics-Accelerated-Technology-Laboratories-and-Digipath.html
Digipath Named Top 10 Cannabis Testing Company in Report by Insight Partners, Market Expected to Reach $2.5 Billion in 2025 https://www.marketwatch.com/press-release/digipath-named-top-10-cannabis-testing-company-in-report-by-insight-partners-market-expected-to-reach-25-billion-in-2025-2019-02-19
Digipath Labs DIGP Stock Dr Cindy Orser MoneyTV Cannabis Data Marijuana Lab Testing
Any more good news this year could catapult the stock much higher such as the actual opening of labs with HEMP,....Colombia, Bogata lab opening by year end....any kind of new partnerships or licensing agreements for cannabis formulations would be very positive. With Cannabis companies moving to major exchanges maybe Digipath would initiate uplisting eventually.....assuming the revenues start to explode.
Seems to have been alot of stock purchases as well as new stock options awarded to Digipath execs. When the stock was much lower execs were buying. I think Digipath is setting up for expansion and growth this year and execs are pretty confident about this. Digipath stock has made a huge spike upwards this past month and now we have the obvious shakeout before shares move much higher in my opinion.
http://m2compliance.com/hosting/company/DIGP/filings.html
I agree. When it doesn't fall through the floor, traders will bid it up again.
Digipath labs opening at HEMP facilities (3 to start) at no cost to them and they will have full ownership of the labs is a good step in the right direction. HEMP is expanding to more state and I assume Digipath Labs will open more labs along with them. The passing of the farm bill for hemp is big business for Digipath soon. Also Digipath is going to license out their cannabis formulations. They have IP which is undervalued.
this is consolidation time. I anticipate another strong move higher soon. I would eye the .50 level as long-term resistance.
Digipath stock broke out from a double bottom recently. It broke out very strong with recent good news related to partnership with HEMP and expectations for a lab opening in Colombia soon.
all cannabis related stocks are crazytown....they all get their moment to shine though. The lab testing angle I think will be very lucrative. If the Colombian market for import/export of cannabis is as big as Digipath CEO syas it will be then we could see some huge gains here.
At some point legalization at the federal level will happen and banks will be receptive to backing the industry with easy capital.
Colombia represents a huge opportunity for Digipath. Also Digipath will be opening 3 more labs at no cost to them at HEMP production facilities. That is a guaranteed win. Riding the backs of HEMP at no cost sounds good to me. I think Digipath is worth holding a speculative position.
Digipath is in the process of laying the groundwork for huge growth. Todd Denkin, Digipath's President & CEO, commented, "Our first fiscal quarter of 2019 continued to show solid quarterly growth from our Nevada operations. We are now actively working to streamline operations, while aggressively working on our expansion initiatives. With much of the original costs to perfect our testing model and make it more efficient now behind us, we believe now is the ideal time to bring our talents to the California and international markets."
Digipath looking to secure a first-mover advantage with their new hire in Colombia. The South American market for cannabis will be huge.
today looks like a shakeout to me.
Digipath new hire looks good; Jorge Restrepo's appointment on Monday provides Digipath with a tremendous advocate in his native nation of Colombia where he can leverage a lifetime of relationships to help install Digipath as a Colombian cannabis-testing leader. It is also imperative to note that the veteran Colombian agronomist adds to an already impressive c-suite of leadership inside Digipath a Masters Degree in Public Administration from Harvard University, The Kennedy School of Government.
Same here. I would expect a pullback after the recent spike. Good luck to you as well. With opening of more labs and Colombian expansion plans Digipath looks like a good bet.
all cannabis stocks pulling back today. Nothing but good news for Digipath lately. Colombia prospects moving ahead.
strategic new hire for Digipath yesterday with expansion into Colombian market. Huge opportunity. http://www.baystreet.ca/viewarticle.aspx?id=535191
Do the math folks. Digipath did 2.8 mil in revenue from 1 lab. They will be opening another 3 labs at HEMP facilities that they will fully own plus they will be opening in Bogata, Colombia later this year. Multiple labs means multiple times current revenue. Great time to buy the stock right now.
President Todd Denkin of Digipath, Inc. on Uptick Newswire. Potential for massive growth with Digipath as the cannabis and hemp industry explodes in my opinion.
I have posted plenty of photos on twitter of patients from multiple Oncosec trials that clearly show tumor regression with TAVO. The therapy may not work for everybody but for some it works very well. I would say that if it can save any more lives beyond the standard of care threatment and this is a last line of defense....then it deserves an FDA approval.